Ren Lin

机构：Wuhan University, Renmin Hospital of Wuhan University · ORCID：0000-0002-9402-0883

发表论文 171 篇 · 总被引 2169 次 · h-index 21

代表论文

• Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled Clinical Trial (2025 · Journal of Clinical Oncology · 被引 17)
• Efficacy and safety of third-generation CD19-CAR T cells incorporating CD28 and TLR2 intracellular domains for B-cell malignancies with central nervous system involvement: results of a pivotal trial (2025 · Journal of Translational Medicine · 被引 14)
• Refining Risk Stratification for B-cell Precursor Adult Acute Lymphoblastic Leukemia Treated With a Pediatric-inspired Regimen by Combining IKZF1 Deletion and Minimal Residual Disease (2025 · Transplantation and Cellular Therapy · 被引 7)
• Epidemiology, clinical outcomes, and treatment patterns of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation in China: a scoping review and meta-analysis (2025 · Frontiers in Microbiology · 被引 6)
• Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study (2025 · Frontiers in Immunology · 被引 5)
• Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT (2025 · Blood Cancer Journal · 被引 5)